NSD2 and Miyoshi myopathy: For example, chromosomal translocations t(4;14), t(14;16), and t(14;20) resulting in enhanced expression of NSD2 (MMSET/WHSC1), MAFC and MAFB oncogenes, respectively, are major markers of poor prognosis in MM [37].